HGC Investment Management Inc. - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 5 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
HGC Investment Management Inc. ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q4 2022$793
-99.9%
79,1500.0%0.04%
-35.2%
Q3 2022$794,000
-49.6%
79,150
-50.0%
0.05%
+12.5%
Q2 2022$1,575,000
+101.7%
158,300
+100.0%
0.05%
+2.1%
Q1 2022$781,00079,1500.05%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q1 2023
NameSharesValueWeighting ↓
Altium Capital Management LP 400,000$4,264,0001.59%
Endurant Capital Management LP 195,000$2,079,0000.75%
CVI Holdings, LLC 355,000$3,784,0000.71%
Wealthspring Capital LLC 129,880$1,385,0000.69%
Sio Capital Management, LLC 300,000$3,198,0000.66%
Monashee Investment Management LLC 300,000$3,198,0000.42%
Sage Mountain Advisors LLC 95,970$1,023,0000.34%
683 Capital Management, LLC 600,000$6,396,0000.30%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 200,000$2,138,0000.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$2,132,0000.23%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders